Annual report pursuant to Section 13 and 15(d)

FAIR VALUE MEASUREMENTS (Tables)

v3.22.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table provides the fair value measurement hierarchy of the Company’s assets and liabilities, except for those assets and liabilities that are short term in nature and approximate the fair values, as of the periods presented:
Level 1
Level 2
Level 3
 
Total
As of December 31, 2021
Assets:
Investment – Cansativa     1,458  1,458 
Total Assets $   $   $ 1,458  $ 1,458 
Liabilities:
Loans and borrowings   7,396    7,396 
Warrant liability     2,205  2,205 
Convertible notes   17,699    17,699 
Total Liabilities $   $ 25,095  $ 2,205  $ 27,300 
As of December 31, 2020
Assets:
Investment – Cansativa —  —  1,553  1,553 
Total Assets $ —  $ —  $ 1,553  $ 1,553 
Liabilities:
Loans and borrowings $ —  $ 6,701  $ —  $ 6,701 
Warrant Liability —  —  19,061  $ 19,061 
Convertible notes —  27,142  —  27,142 
Total Liabilities $ —  $ 33,843  $ 19,061  $ 52,904 
Schedule of Changes in the Fair Value of Warrant Liabilities
The change in fair value of warrant liabilities related to private warrants during the year ended December 31, 2021 is as follows:
Private Placement Warrants: Total Warrant Liability
Warrant liability at December 31, 2020 $ 19,061 
Change in fair value of warrant liability (16,856)
Warrant liability at December 31, 2021 $ 2,205 
Fair Value Measurement Inputs and Valuation Techniques The following assumptions were used to determine the fair value of the Private Warrants as of December 31, 2021 and December 31, 2020:
As of
December 31,
2021
December 31,
2020
Risk-free interest rate 1.11  % 0.43  %
Expected volatility 60  % 60  %
Share Price $ 3.10  $ 8.90 
Exercise Price $ 11.50  $ 11.50 
Expiration date December 18, 2025 December 18, 2025

The risk-free interest rate assumptions are based on U.S. dollar zero curve derived from swap rates at the valuation date, with a term to maturity matching the remaining term of warrants.
The expected volatility assumptions are based on average of historical volatility based on comparable industry volatilities of public warrants.
The following table represents the weighted-average assumptions used in the Monte Carlo simulation model to determine the fair value of the market-based restricted share units granted during the twelve months ended December 31, 2021.

Weighted Average Assumptions
December 31, 2021
Grant date share price
$13.68
Risk-free interest rate
0.52%
Expected dividend yield
0.0%
Expected volatility
90%
Expected life (in years)
1.3 - 3.8